rs140804406

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_058216.3(RAD51C):​c.640C>T​(p.Arg214Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000367 in 1,607,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R214H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

RAD51C
NM_058216.3 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:10B:4

Conservation

PhyloP100: 3.87

Publications

9 publications found
Variant links:
Genes affected
RAD51C (HGNC:9820): (RAD51 paralog C) This gene is a member of the RAD51 family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51 and are known to be involved in the homologous recombination and repair of DNA. This protein can interact with other RAD51 paralogs and is reported to be important for Holliday junction resolution. Mutations in this gene are associated with Fanconi anemia-like syndrome. This gene is one of four localized to a region of chromosome 17q23 where amplification occurs frequently in breast tumors. Overexpression of the four genes during amplification has been observed and suggests a possible role in tumor progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
RAD51C Gene-Disease associations (from GenCC):
  • RAD51C-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Fanconi anemia complementation group O
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07894361).
BP6
Variant 17-58703264-C-T is Benign according to our data. Variant chr17-58703264-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 141324.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_058216.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAD51C
NM_058216.3
MANE Select
c.640C>Tp.Arg214Cys
missense
Exon 4 of 9NP_478123.1O43502-1
RAD51C
NR_103872.2
n.515C>T
non_coding_transcript_exon
Exon 3 of 8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAD51C
ENST00000337432.9
TSL:1 MANE Select
c.640C>Tp.Arg214Cys
missense
Exon 4 of 9ENSP00000336701.4O43502-1
RAD51C
ENST00000482007.5
TSL:1
n.*68C>T
non_coding_transcript_exon
Exon 3 of 8ENSP00000433332.1Q7KZJ0
RAD51C
ENST00000482007.5
TSL:1
n.*68C>T
3_prime_UTR
Exon 3 of 8ENSP00000433332.1Q7KZJ0

Frequencies

GnomAD3 genomes
AF:
0.000164
AC:
25
AN:
152138
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000716
AC:
18
AN:
251226
AF XY:
0.0000589
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000234
AC:
34
AN:
1455710
Hom.:
0
Cov.:
31
AF XY:
0.0000235
AC XY:
17
AN XY:
724586
show subpopulations
African (AFR)
AF:
0.000720
AC:
24
AN:
33334
American (AMR)
AF:
0.0000224
AC:
1
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.0000758
AC:
3
AN:
39592
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86108
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53324
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00000181
AC:
2
AN:
1106640
Other (OTH)
AF:
0.0000498
AC:
3
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000164
AC:
25
AN:
152256
Hom.:
0
Cov.:
31
AF XY:
0.000161
AC XY:
12
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.000506
AC:
21
AN:
41542
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000658
Hom.:
0
Bravo
AF:
0.000204
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Hereditary cancer-predisposing syndrome (3)
-
2
-
Fanconi anemia complementation group O;C3150659:Breast-ovarian cancer, familial, susceptibility to, 3 (2)
-
2
-
not provided (2)
-
2
-
not specified (2)
-
1
-
Breast and/or ovarian cancer (1)
-
-
1
Breast-ovarian cancer, familial, susceptibility to, 3 (1)
-
1
-
Fanconi anemia complementation group O (1)
-
-
1
Ovarian cancer (1)
-
1
-
RAD51C-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.017
T
Eigen
Benign
0.13
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.93
D
M_CAP
Benign
0.0077
T
MetaRNN
Benign
0.079
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.68
N
PhyloP100
3.9
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.098
Sift
Benign
0.28
T
Sift4G
Benign
0.21
T
Polyphen
0.0010
B
Vest4
0.40
MVP
0.83
MPC
0.31
ClinPred
0.037
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.22
gMVP
0.46
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140804406; hg19: chr17-56780625; COSMIC: COSV61676404; API